Table 5.
Descriptive analysis of DLQI (comparing ex-CHM with other therapies for psoriasis vulgaris treatment)
| Study | Sample size (E/C) | Intervention (E/C) |
MD (95%CI) |
P value |
|---|---|---|---|---|
| Su et al 201523 | 42/43 | CHM bath+308nm excimer laser/308 nm excimer laser | -2.67 (-4.91, -0.43) (-4.91, -0.43) |
0.02 |
| excimer laser | ||||
| Fan 201627 | 30/30 | CHM bath+NB-UVB/NB-UVB | -1.56 (-2.66, -0.46) (-2.66, -0.46) |
0.005 |
| Song et al 201729 | 42/42 | CHM bath+NB-UVB+urea ointment /NB-UVB+urea ointment |
-5.29 (-7.20, -3.38) |
<0.00001 |
| Li et al 201221 | 30/30 | CHM bath+NB-UVB+ex-hormone /NB-UVB+ex-hormone |
-3.63 (-5.93, -1.33) |
0.002 |
Notes: CHM: Chinese Herbal Medicine; ex-CHM: external application of CHM; Ex-hormone: external application of hormone; NB-UVB: narrow-band ultraviolet B; DLQI: dermatology life quality index; MD: mean difference; CI: confidence interval; E: the experiment group; C: the control group.